Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Abiosa Pharma AS
AS
Active
Org 918832424
Prost Stabels Vei 460, 2019
Skedsmokorset
Intermediation service activities for specialised retail sale
·
NACE 4792
Est. 2017 · 9 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Intermediation service activities for specialised retail sale
/
Abiosa Pharma AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
HB
Henning Bakke
Board of Directors
Board of Directors
2017
EB
Edita Bakke
Board of Directors
Board of Directors
2017
KH
Kjell Hans Bakke
Chairman
Chairman
2017
Shareholders
As of last annual report
Bakke Consulting As — 45%
Henning Bakke — 22.67%
Edita Bakke — 22.33%
Kjell Hans Bakke — 10%
100%
Shareholder
Type
Ownership
Votes
Since
Bakke Consulting As
Company
45%
45%
2025
Henning Bakke
Individual
22.67%
22.67%
2025
Edita Bakke
Individual
22.33%
22.33%
2025
Kjell Hans Bakke
Individual
10%
10%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Abiosa Pharma AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
